Abstract
Carica papaya Linn is widely known as a medicinal fruit. We sought to study a standardized fermented papaya preparation (FPP) for its effects on wound healing in adult obese diabetic (db/db) mice. FPP blunted the gain in blood glucose and improved the lipid profile after 8 weeks of oral supplementation. However, FPP did not influence weight gain during the supplementation period. FPP (0.2 g/kg body weight) supplementation for 8 weeks before wounding was effective in correcting wound closure. Studies on viable macrophages isolated from the wound site demonstrated that FPP supplementation improved respiratory-burst function as well as inducible NO production. Reactive oxygen species support numerous aspects of wound healing; NO availability in diabetic wounds is known to be compromised. Diabetic mice supplemented with FPP showed a higher abundance of CD68 as well as CD31 at the wound site, suggesting effective recruitment of monocytes and an improved proangiogenic response. This work provides the first evidence that diabetic-wound outcomes may benefit from FPP supplementation by specifically influencing the response of wound-site macrophages and the subsequent angiogenic response. Given that FPP has a long track record of safe human consumption, testing of the beneficial effects of FPP on diabetic wound-related outcomes in a clinical setting is warranted.
Publication types
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Antigens, CD / genetics
-
Antigens, Differentiation, Myelomonocytic / genetics
-
Blood / drug effects
-
Blood Glucose / drug effects
-
Blood Glucose / metabolism
-
Body Weight / drug effects
-
Carica*
-
Diabetes Complications / metabolism
-
Diabetes Complications / pathology
-
Diabetes Complications / therapy*
-
Diabetes Mellitus / blood
-
Diabetes Mellitus / genetics
-
Dietary Supplements
-
Endothelial Cells / drug effects
-
Endothelial Cells / metabolism
-
Fermentation*
-
Fruit / microbiology*
-
Gene Expression / drug effects
-
Gene Expression / genetics
-
Insulin / blood
-
Lipids / blood
-
Lipopolysaccharides / pharmacology
-
Lipoproteins / blood
-
Macrophages / drug effects
-
Macrophages / metabolism
-
Male
-
Mice
-
Mice, Obese
-
Nitric Oxide / metabolism
-
Nitric Oxide Synthase Type II / genetics
-
Plant Preparations / administration & dosage*
-
Plant Preparations / pharmacology
-
Plant Preparations / therapeutic use*
-
Platelet Endothelial Cell Adhesion Molecule-1 / metabolism
-
Reactive Oxygen Species / metabolism
-
Superoxides / metabolism
-
Tetradecanoylphorbol Acetate / pharmacology
-
Vascular Endothelial Growth Factor A / genetics
-
Wound Healing / drug effects*
-
Wounds and Injuries / metabolism
-
Wounds and Injuries / pathology
-
Wounds and Injuries / therapy
Substances
-
Antigens, CD
-
Antigens, Differentiation, Myelomonocytic
-
Blood Glucose
-
CD68 protein, mouse
-
Insulin
-
Lipids
-
Lipopolysaccharides
-
Lipoproteins
-
Plant Preparations
-
Platelet Endothelial Cell Adhesion Molecule-1
-
Reactive Oxygen Species
-
Vascular Endothelial Growth Factor A
-
vascular endothelial growth factor A, mouse
-
Superoxides
-
Nitric Oxide
-
Nitric Oxide Synthase Type II
-
Nos2 protein, mouse
-
Tetradecanoylphorbol Acetate